Herpes oncolytic therapy of salivary gland carcinomas.

Herpes oncolytic therapy of salivary gland carcinomas. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Herpes oncolytic therapy of salivary gland carcinomas. Abstract Text:

Vincent Reid,Zhenkun Yu,Theodore Schuman,Sen Li,Paramjeet Singh,Yuman Fong,Richard J Wong,Vincent Reid,Zhenkun Yu,Theodore Schuman,Sen Li,Paramjeet Singh,Yuman Fong,Richard J Wong,

Oncolytic herpes simplex viruses (HSV) have demonstrated potent antitumoral effects against a variety of human malignancies in preclinical studies and are in early clinical trials. We explored the activity of an attenuated, replication-competent, oncolytic HSV (NV1023) for the treatment of human salivary gland carcinomas. NV1023 was able to successfully enter into 4 mucoepidermoid carcinoma (H292, H3118, HTB-41, UT-MUC-1) and 2 adenocarcinoma (HSY, HSG) cell lines, as measured by lacZ assays after exposure to 5 viral particles per cell (MOI 5). Viral plaque assays showed variation of viral replication within these cell lines, ranging from a 268-fold increase (H292) to a 3-fold increase (HSG) in viral titer. At MOI 5, all cell lines showed >95% cytotoxicity from NV1023 by Day 7, except for HSY (73%). At MOI 0.1, H3118 and UT-MUC-1 remained highly sensitive to NV1023, both showing >95% cytotoxicity by Day 7. The mucoepidermoid carcinomas were more sensitive to NV1023 at low viral concentrations compared with the adenocarcinomas. Flank tumors of H3118, HTB-41 and HSY in nude mice showed significant tumor volume reductions after a single intratumoral injection of NV1023 (2 x 10(7) plaque-forming units). These data suggest that oncolytic herpes viruses have significant efficacy entering, replicating within, and lysing human salivary gland carcinomas. These promising biologic agents should be further investigated as novel therapy for patients with salivary carcinomas failing conventional treatment.

Herpes oncolytic therapy of salivary gland carcinomas. Publishing Authors By Initials

V Reid,Z Yu,T Schuman,S Li,P Singh,Y Fong,RJ Wong,V Reid,Z Yu,T Schuman,S Li,P Singh,Y Fong,RJ Wong,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Herpes oncolytic therapy of salivary gland carcinomas. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: International journal of cancer. Journal internati

VOLUME: 122

Page Numbers: 202-8

Journal Abbreviation: Int. J. Cancer

ISSN: 1097-0215

DAY: 1

MONTH: Jan

YEAR: 2008

Herpes oncolytic therapy of salivary gland carcinomas. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 42124

Herpes oncolytic therapy of salivary gland carcinomas. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Herpes oncolytic therapy of salivary gland carcinomas. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Herpes oncolytic therapy of salivary gland carcinomas.

AFFILIATION: Head and Neck Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Int J Cancer

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Herpes oncolytic therapy of salivary gland carcinomas Related Publications

• A simple microindentation technique for mapping the microscale compliance of soft hydrated materials and tissues.
• A study of density of states and ground states in hydrophobic-hydrophilic protein folding models by equi-energy sampling.
• An extended simplified reference tissue model for the quantification of dynamic PET with amphetamine challenge.
• Cell cycle dysregulation in oral cancer.
• Characterization of a transglycosylase domain of Streptococcus pneumoniae PBP1b.
• Differentially expressed protein markers in human submandibular and sublingual secretions.
• Dose effects of triazolam on brain activity during episodic memory encoding: a PET study.
• Driver perception response time during the signal change interval.
• Expression of cell-cycle regulator CDK2-associating protein 1 (p12CDK2AP1) in transgenic mice induces testicular and ovarian atrophy in vivo.
• Extracellular heat shock protein-70 induces endotoxin tolerance in THP-1 cells.
• Feruloyl esterase: a key enzyme in biomass degradation.
• German cockroach proteases regulate matrix metalloproteinase-9 in human bronchial epithelial cells.
• HIV Evolution and Escape.
• Health services utilization for people with HIV infection: comparison of a population targeted for outreach with the U.S. population in care.
• In vivo imaging reveals dendritic targeting of laminated afferents by zebrafish retinal ganglion cells.
• In vivo optical coherence tomography of the nasal mucosa.
• Measurement of serum D-arabinitol/creatinine ratios for initial diagnosis and for predicting outcome in an unselected, population-based sample of patients with Candida fungemia.
• Mechanism and function of heat shock-dependent IkappaBalpha expression.
• Mycotic aortic aneurysm following treatment of pyogenic vertebral osteomyelitis.
• Prediction of breast cancer using volatile biomarkers in the breath.
• Prolonged and severe dysphagia following anterior cervical surgery.
• Sugar-assisted ligation of N-linked glycopeptides with broad sequence tolerance at the ligation junction.
• The executive clock drawing task (CLOX) is a poor screening test for executive dysfunction in Chinese elderly patients with subcortical ischemic vascular disease.
• The relationship between parent emotion, parent behavior, and health status of young African American and Latino children.
• [Advances of fine needle aspiration cytology]
• [Biosynthesis and characterization of jarosite]
• [Creation of the World Federation of Critical Care Nursing (WFCCN)]
• [Effect of oxygen on the fluorescence of sol-gel with ruthenium complexes]
• [In Process Citation]
• c-Jun NH(2)-terminal kinase 2alpha2 promotes the tumorigenicity of human glioblastoma cells.